Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study
Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.49 -0.08 (14.04%)
Previous Close $0.57    52 Week High $0.00 
Open $0.57    52 Week Low $0.00 
Day High $0.57    P/E N/A 
Day Low $0.47    EPS $0.00 
Volume 297,797       

Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.49 -0.08 (14.04%)
Previous Close $0.57    52 Week High $0.00 
Open $0.57    52 Week Low $0.00 
Day High $0.57    P/E N/A 
Day Low $0.47    EPS $0.00 
Volume 297,797       

Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.49 -0.08 (14.04%)
Previous Close $0.57    52 Week High $0.00 
Open $0.57    52 Week Low $0.00 
Day High $0.57    P/E N/A 
Day Low $0.47    EPS $0.00 
Volume 297,797